共 50 条
[31]
Predictive Polygenic Score for Outcome after First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients Using Supervised Principal Component Analysis
[J].
Park, Hanla A.
;
Edelmann, Dominic
;
Canzian, Federico
;
Harrison, Tabitha A.
;
Hua, Xinwei
;
Shi, Qian
;
Silverman, Allison
;
Schneider, Martin
;
Goldberg, Richard M.
;
Alberts, Steven R.
;
Hoffmeister, Michael
;
Brenner, Hermann
;
Chan, Andrew T.
;
Peters, Ulrike
;
Newcomb, Polly A.
;
Chang-Claude, Jenny
.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION,
2022, 31 (11)
:2087-2091

Park, Hanla A.
论文数: 0 引用数: 0
h-index: 0
机构:
German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
Heidelberg Univ, Med Fac, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Edelmann, Dominic
论文数: 0 引用数: 0
h-index: 0
机构:
German Canc Res Ctr, Div Biostat, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Canzian, Federico
论文数: 0 引用数: 0
h-index: 0
机构:
German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Harrison, Tabitha A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Hua, Xinwei
论文数: 0 引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA
Harvard Med Sch, Boston, MA 02115 USA
Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA
Peking Univ, Peking Univ Third Hosp, Dept Cardiol, Beijing, Peoples R China German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Shi, Qian
论文数: 0 引用数: 0
h-index: 0
机构:
Mayo Clin, Dept Quantitat Sci, Rochester, MN USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Silverman, Allison
论文数: 0 引用数: 0
h-index: 0
机构:
Fred Hutchinson Res Canc Res Ctr, Epidemiol Program, Seattle, WA USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Schneider, Martin
论文数: 0 引用数: 0
h-index: 0
机构:
Heidelberg Univ, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Goldberg, Richard M.
论文数: 0 引用数: 0
h-index: 0
机构:
West Virginia Univ Canc Inst, Morgantown, WV USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Alberts, Steven R.
论文数: 0 引用数: 0
h-index: 0
机构:
Mayo Clin, Med Oncol, Rochester, MN USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Hoffmeister, Michael
论文数: 0 引用数: 0
h-index: 0
机构:
German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Brenner, Hermann
论文数: 0 引用数: 0
h-index: 0
机构:
German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
Natl Ctr Tumor Dis NCT, Div Prevent Oncol, Heidelberg, Germany
German Canc Res Ctr, Heidelberg, Germany
German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Chan, Andrew T.
论文数: 0 引用数: 0
h-index: 0
机构:
Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA
Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Peters, Ulrike
论文数: 0 引用数: 0
h-index: 0
机构:
Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA
Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Newcomb, Polly A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA
Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany

Chang-Claude, Jenny
论文数: 0 引用数: 0
h-index: 0
机构:
German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
Univ Canc Ctr Hamburg, Univ Med Ctr Hamburg Eppendorf, Canc Epidemiol Grp, Hamburg, Germany German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[32]
Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy
[J].
Mizushima, Tsunekazu
;
Fukunaga, Mutsumi
;
Sueda, Toshinori
;
Ikeda, Masataka
;
Kato, Takeshi
;
Kim, Ho Min
;
Kudo, Toshihiro
;
Murata, Kohei
;
Nishimura, Junichi
;
Hata, Taishi
;
Matsuda, Chu
;
Yamamoto, Hirofumi
;
Doki, Yuichiro
;
Mori, Masaki
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
2017, 80 (01)
:81-90

Mizushima, Tsunekazu
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Osaka Univ, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Fukunaga, Mutsumi
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Sakai City Med Ctr, Dept Surg, Sakai, Osaka, Japan
Hyogo Prefectural Nishinomiya Hosp, Dept Surg, Nishinomiya, Hyogo, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Sueda, Toshinori
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Osaka Univ, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Ikeda, Masataka
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Natl Hosp Org Osaka Natl Hosp, Dept Surg, Osaka, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Kato, Takeshi
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Kim, Ho Min
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Osaka Rosai Hosp, Dept Surg, Sakai, Osaka, Japan
Rinku Gen Med Ctr, Dept Surg, Izumisano, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Kudo, Toshihiro
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Osaka Univ, Dept Frontier Sci Canc & Chemotherapy, Grad Sch Med, Osaka, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Murata, Kohei
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Suita Municipal Hosp, Dept Surg, Suita, Osaka, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

论文数: 引用数:
h-index:
机构:

Hata, Taishi
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Osaka Univ, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Matsuda, Chu
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Osaka Univ, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

Yamamoto, Hirofumi
论文数: 0 引用数: 0
h-index: 0
机构:
Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan
Osaka Univ, Dept Surg, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan Osaka Univ CSGO, Clin Study Grp, Colorectal Grp, Osaka, Japan

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:
[33]
A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study
[J].
Sato, Yasushi
;
Hirakawa, Masahiro
;
Ohnuma, Hiroyuki
;
Takahashi, Minoru
;
Okamoto, Tetsuro
;
Okamoto, Koichi
;
Miyamoto, Hiroshi
;
Muguruma, Naoki
;
Furuhata, Tomohisa
;
Takemasa, Ichiro
;
Kato, Junji
;
Takayama, Tetsuji
.
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
2017, 80 (06)
:1133-1139

Sato, Yasushi
论文数: 0 引用数: 0
h-index: 0
机构:
Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Hirakawa, Masahiro
论文数: 0 引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Dept Med Oncol, Sch Med, Sapporo, Hokkaido, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Ohnuma, Hiroyuki
论文数: 0 引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Dept Med Oncol, Sch Med, Sapporo, Hokkaido, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Takahashi, Minoru
论文数: 0 引用数: 0
h-index: 0
机构:
Sapporo Kyoritsu Gorinbashi Hosp, Div Gastroenterol, Sapporo, Hokkaido, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Okamoto, Tetsuro
论文数: 0 引用数: 0
h-index: 0
机构:
Kiyota Hosp, Div Gastroenterol, Sapporo, Hokkaido, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Okamoto, Koichi
论文数: 0 引用数: 0
h-index: 0
机构:
Tokushima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Miyamoto, Hiroshi
论文数: 0 引用数: 0
h-index: 0
机构:
Tokushima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Muguruma, Naoki
论文数: 0 引用数: 0
h-index: 0
机构:
Tokushima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Furuhata, Tomohisa
论文数: 0 引用数: 0
h-index: 0
机构:
St Marianna Univ, Toyoko Hosp, Dept Surg Gastroenterol, Yokohama, Kanagawa, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Takemasa, Ichiro
论文数: 0 引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Sch Med, Dept Surg Surg Oncol & Sci, Sapporo, Hokkaido, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Kato, Junji
论文数: 0 引用数: 0
h-index: 0
机构:
Sapporo Med Univ, Dept Med Oncol, Sch Med, Sapporo, Hokkaido, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan

Takayama, Tetsuji
论文数: 0 引用数: 0
h-index: 0
机构:
Tokushima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan Tokushima Univ, Grad Sch Biomed Sci, Dept Community Med Gastroenterol & Oncol, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan
[34]
A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer
[J].
Xiong, Jian Ping
;
Zhang, Ling
;
Zhong, Lu Xing
;
Qiu, Feng
;
Xu, Jun
;
Tao, Qing Song
;
Xiang, Xiao Jun
;
Yu, Feng
;
Tang, Xiao Mei
.
ANTI-CANCER DRUGS,
2007, 18 (09)
:1103-1107

Xiong, Jian Ping
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Zhang, Ling
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Zhong, Lu Xing
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Qiu, Feng
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Xu, Jun
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Tao, Qing Song
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Xiang, Xiao Jun
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Yu, Feng
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China

Tang, Xiao Mei
论文数: 0 引用数: 0
h-index: 0
机构:
Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang 330006, Peoples R China
[35]
Cetuximab or BevacizumabWith First-Line Chemotherapy in Advanced KRAS Wild-Type Colorectal Cancer No Difference, but Not the Same
[J].
Lieu, Christopher H.
;
Messersmith, Wells A.
.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
2017, 317 (23)
:2376-2378

Lieu, Christopher H.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Colorado, Denver, CO 80202 USA Univ Colorado, Denver, CO 80202 USA

Messersmith, Wells A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Colorado, Denver, CO 80202 USA Univ Colorado, Denver, CO 80202 USA
[36]
Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer
[J].
Yoshito Komatsu
;
Chikashi Ishioka
;
Ken Shimada
;
Yasuhide Yamada
;
Makio Gamoh
;
Atsushi Sato
;
Tatsuro Yamaguchi
;
Satoshi Yuki
;
Satoshi Morita
;
Shin Takahashi
;
Rei Goto
;
Minoru Kurihara
.
BMC Cancer,
15

Yoshito Komatsu
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Chikashi Ishioka
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Ken Shimada
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Yasuhide Yamada
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Makio Gamoh
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Atsushi Sato
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Tatsuro Yamaguchi
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Satoshi Yuki
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Satoshi Morita
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

论文数: 引用数:
h-index:
机构:

Rei Goto
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy

Minoru Kurihara
论文数: 0 引用数: 0
h-index: 0
机构: Hokkaido University Hospital Cancer Center,Department of Cancer Chemotherapy
[37]
Cost-effectiveness analysis of cetuximab combined with chemotherapy as a first-line treatment for patients with RAS wild-type metastatic colorectal cancer based on the TAILOR trial
[J].
Wang, Huijuan
;
Huang, Lingfei
;
Gao, Peng
;
Zhu, Zhengyi
;
Ye, Weifeng
;
Ding, Haiying
;
Fang, Luo
.
BMJ OPEN,
2020, 10 (02)

Wang, Huijuan
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China

Huang, Lingfei
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China

Gao, Peng
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China

Zhu, Zhengyi
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China

Ye, Weifeng
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China

Ding, Haiying
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Canc Hosp, Dept Pharm, Hangzhou, Peoples R China Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China

Fang, Luo
论文数: 0 引用数: 0
h-index: 0
机构:
Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China Zhejiang Univ, Childrens Hosp, Dept Pharm, Natl Clin Res Ctr Child Hlth,Sch Med, Hangzhou, Peoples R China
[38]
Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping
[J].
Papaxoinis, George
;
Kotoula, Vassiliki
;
Giannoulatou, Eleni
;
Koliou, Georgia-Angeliki
;
Karavasilis, Vasilios
;
Lakis, Sotirios
;
Koureas, Andreas
;
Bobos, Mattheos
;
Chalaralambous, Elpida
;
Daskalaki, Emily
;
Chatzopoulos, Kyriakos
;
Tsironis, George
;
Pazarli, Elisavet
;
Chrisafi, Sofia
;
Samantas, Epaminontas
;
Kaklamanos, Ioannis G.
;
Varthalitis, Ioannis
;
Konstantara, Athina
;
Syrigos, Konstantinos N.
;
Pentheroudakis, George
;
Pectasides, Dimitrios
;
Fountzilas, George
.
MEDICAL ONCOLOGY,
2018, 35 (07)

Papaxoinis, George
论文数: 0 引用数: 0
h-index: 0
机构:
Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Kotoula, Vassiliki
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Fac Med, Sch Hlth Sci, Dept Pathol, Thessaloniki, Greece
Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Giannoulatou, Eleni
论文数: 0 引用数: 0
h-index: 0
机构:
Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia
Univ New South Wales, Kensington, NSW, Australia Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Koliou, Georgia-Angeliki
论文数: 0 引用数: 0
h-index: 0
机构:
Hellen Cooperat Oncol Grp, Data Off, Sect Biostat, Athens, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Karavasilis, Vasilios
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Papageorgiou Hosp, Sch Hlth Sci, Dept Med Oncol,Fac Med, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Lakis, Sotirios
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Koureas, Andreas
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Athens, Aretaieio Hosp, Dept Radiol, Athens, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Bobos, Mattheos
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Chalaralambous, Elpida
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Daskalaki, Emily
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Fac Med, Sch Hlth Sci, Dept Pathol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Chatzopoulos, Kyriakos
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Tsironis, George
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Sch Med, Athens, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Pazarli, Elisavet
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Fac Med, Sch Hlth Sci, Dept Pathol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Chrisafi, Sofia
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Samantas, Epaminontas
论文数: 0 引用数: 0
h-index: 0
机构:
Agii Anargiri Canc Hosp, Dept Med Oncol 3, Athens, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Kaklamanos, Ioannis G.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Athens, Gen Oncol Hosp Kifisia, Sch Hlth Sci, Dept Surg, Athens, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Varthalitis, Ioannis
论文数: 0 引用数: 0
h-index: 0
机构:
Gen Hosp Chania, Oncol Dept, Iraklion, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Konstantara, Athina
论文数: 0 引用数: 0
h-index: 0
机构:
St Lukes Hosp, Dept Surg, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Syrigos, Konstantinos N.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Athens, Sotiria Gen Hosp, Oncol Unit GPP, Sch Med, Athens, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Pentheroudakis, George
论文数: 0 引用数: 0
h-index: 0
机构:
Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Pectasides, Dimitrios
论文数: 0 引用数: 0
h-index: 0
机构:
Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece

Fountzilas, George
论文数: 0 引用数: 0
h-index: 0
机构:
Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Lab Mol Oncol, Thessaloniki, Greece
Aristotle Univ Thessaloniki, Thessaloniki, Greece Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens 11527, Greece
[39]
Avelumab in Combination With Cetuximab and Chemotherapy as First-Line Treatment for Patients With Advanced Squamous NSCLC
[J].
Andric, Zoran
;
Galffy, Gabriella
;
Dols, Manuel Cobo
;
Szima, Barna
;
Stojanovic, Goran
;
Petrovic, Marina
;
Felip, Enriqueta
;
Baz, David Vicente
;
Aix, Santiago Ponce
;
Juan-Vidal, Oscar
;
Szalai, Zsuzsanna
;
Losonczy, Gyorgy
;
Blanco, Antonio Calles
;
Bernabe, Reyes
;
Ledo, Gema Garcia
;
Hernandez, Andres Aguilar
;
Duecker, Klaus
;
Zhou, Dongli
;
Schroeder, Andreas
;
Guezel, Guelseren
;
Ciardiello, Fortunato
.
JTO CLINICAL AND RESEARCH REPORTS,
2023, 4 (02)

Andric, Zoran
论文数: 0 引用数: 0
h-index: 0
机构:
Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Galffy, Gabriella
论文数: 0 引用数: 0
h-index: 0
机构:
Pulmonol Hosp Torokbalint, Torokbalint, Hungary Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Dols, Manuel Cobo
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Reg Univ Malaga, Inst Biomed Res Malaga IBIMA, Dept Med Oncol, Malaga, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Szima, Barna
论文数: 0 引用数: 0
h-index: 0
机构:
Markusovszky Hosp, Dept Pulmonol, Szombathely, Hungary Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Stojanovic, Goran
论文数: 0 引用数: 0
h-index: 0
机构:
Inst Pulm Dis Vojvodina, Sremska Kamenica, Serbia Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Petrovic, Marina
论文数: 0 引用数: 0
h-index: 0
机构:
Clin Ctr Kragujevac, Clin Pulmonol, Kragujevac, Serbia Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Felip, Enriqueta
论文数: 0 引用数: 0
h-index: 0
机构:
Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Baz, David Vicente
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Virgen Macarena, Dept Med Oncol, Seville, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Aix, Santiago Ponce
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ 12 Octubre, Med Oncol Dept, H120 CNIO Lung Canc Unit, Madrid, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Juan-Vidal, Oscar
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ & Politecn La Fe, Med Oncol Dept, Valencia, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Szalai, Zsuzsanna
论文数: 0 引用数: 0
h-index: 0
机构:
Aladar Petz Univ, Dept Pulmonol, Teaching Hosp, Gyor, Hungary Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Losonczy, Gyorgy
论文数: 0 引用数: 0
h-index: 0
机构:
Semmelweis Univ, Fac Med, Budapest, Hungary Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Blanco, Antonio Calles
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Bernabe, Reyes
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ Virgen Rocio, Dept Med Oncol, Seville, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Ledo, Gema Garcia
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ HM Sanchinarro, Ctr Integral Oncol Clara Campal HM CIOCC, Madrid, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Hernandez, Andres Aguilar
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Quiron Dexeus, Inst Oncol Dr Rosell, Barcelona, Spain Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Duecker, Klaus
论文数: 0 引用数: 0
h-index: 0
机构:
Healthcare Business Merck KGaA, Darmstadt, Germany Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Zhou, Dongli
论文数: 0 引用数: 0
h-index: 0
机构:
Merck Serono Beijing Pharmaceut R&D Co Ltd, Beijing, Peoples R China
Merck KGaA, Darmstadt, Germany Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Schroeder, Andreas
论文数: 0 引用数: 0
h-index: 0
机构:
Healthcare Business Merck KGaA, Darmstadt, Germany Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Guezel, Guelseren
论文数: 0 引用数: 0
h-index: 0
机构:
Healthcare Business Merck KGaA, Darmstadt, Germany Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia

Ciardiello, Fortunato
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Campania Luigi Vanvitelli, Dept Precis Med, Div Med Oncol, Naples, Italy Clin Hosp Ctr Bezanijska Kosa, Dept Med Oncol, Belgrade, Serbia
[40]
Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer
[J].
Whyte, S.
;
Pandor, A.
;
Stevenson, M.
;
Rees, A.
.
HEALTH TECHNOLOGY ASSESSMENT,
2010, 14
:47-53

论文数: 引用数:
h-index:
机构:

Pandor, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Sheffield, ScHARR Technol Assessment Grp, Sheffield, S Yorkshire, England Univ Sheffield, ScHARR Technol Assessment Grp, Sheffield, S Yorkshire, England

Stevenson, M.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Sheffield, ScHARR Technol Assessment Grp, Sheffield, S Yorkshire, England Univ Sheffield, ScHARR Technol Assessment Grp, Sheffield, S Yorkshire, England

Rees, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Sheffield, ScHARR Technol Assessment Grp, Sheffield, S Yorkshire, England Univ Sheffield, ScHARR Technol Assessment Grp, Sheffield, S Yorkshire, England